Evidence map›Paper›PMID 24990380›Full record

ArticleNucleic acids research2014

Analysis of neonatal brain lacking ATRX or MeCP2 reveals changes in nucleosome density, CTCF binding and chromatin looping.

Kristin D Kernohan, Douglas Vernimmen, Gregory B Gloor, Nathalie G Bérubé

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Alternative Lengthening of Telomeres: The Need forInternational journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Mutant ATRX: pathogenesis of ATRX syndrome and cancer.Frontiers in molecular biosciences · 2024
    Review
  12. Review
  13. Multiple Roles of dXNP and dADD1-International journal of molecular sciences · 2023
    Review
  14. Article
  15. The MECP2-TRD domain interacts with the DNMT3A-ADD domain at the H3-tail binding site.Protein science : a publication of the Protein Society · 2023
    Article
  16. Article
  17. Article
  18. Rett Syndrome andNeuropsychiatric disease and treatment · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Kristin D KernohanDepartment of Biochemistry, University of Western Ontario, London N6C 2V5, Canada Children's Health Research Institute, London, Canada.
Douglas VernimmenMedical Research Council (MRC) Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Gregory B GloorDepartment of Biochemistry, University of Western Ontario, London N6C 2V5, Canada.
Nathalie G BérubéDepartment of Biochemistry, University of Western Ontario, London N6C 2V5, Canada Children's Health Research Institute, London, Canada Department of Paediatrics, University of Western Ontario, London N6C 2V5, Canada nberube@uwo.ca.
Western University · CAChildren’s Health Research Institute · CAMedical Research Council · GB

Funding

Canadian Institutes of Health Research MOP93697
6 · The paper itself

Abstract

ATRX and MeCP2 belong to an expanding group of chromatin-associated proteins implicated in human neurodevelopmental disorders, although their gene-regulatory activities are not fully resolved. Loss of ATRX prevents full repression of an imprinted gene network in the postnatal brain and in this study we address the mechanistic aspects of this regulation. We show that ATRX binds many imprinted domains individually but that transient co-localization between imprinted domains in the nuclei of neurons does not require ATRX. We demonstrate that MeCP2 is required for ATRX recruitment and that deficiency of either ATRX or MeCP2 causes decreased frequency of long-range chromatin interactions associated with altered nucleosome density at CTCF-binding sites and reduced CTCF occupancy. These findings indicate that MeCP2 and ATRX regulate gene expression at a subset of imprinted domains by maintaining a nucleosome configuration conducive to CTCF binding and to the maintenance of higher order chromatin structure.

Indexed as

Genomic ImprintingAnimalsBinding SitesBrainCalcium-Binding ProteinsCCCTC-Binding FactorCell NucleusChromatinDNA HelicasesGene DeletionInsulin-Like Growth Factor IIIntercellular Signaling Peptides and ProteinsMethyl-CpG-Binding Protein 2MiceNeuronsNuclear ProteinsAtrx protein, mouseCalcium-Binding ProteinsCCCTC-Binding FactorChromatinCTCF protein, humanCtcf protein, mouseDlk1 protein, mouseDNA HelicasesH19 long non-coding RNAInsulin-Like Growth Factor IIIntercellular Signaling Peptides and ProteinsMecp2 protein, mouseMEG3 non-coding RNA, mouseMethyl-CpG-Binding Protein 2Nuclear ProteinsNucleosomesRepressor ProteinsRNA, Long NoncodingX-linked Nuclear Protein

Identifiers

PMID24990380
PMCPMC4117782
OpenAlexW1980912145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.